Who are the key players in North America Autoimmune Disease Diagnosis Market industry?

The top five key players include Abbott Laboratories, Thermo Fisher Scientific, Bio-Rad Laboratories, Siemens Healthineers, and F. Hoffmann-La Roche AG. These companies are prominent due to their advanced diagnostic technologies, extensive product portfolios, and significant market presence, driving innovation and competition in the North American autoimmune disease diagnostics landscape.

What are the factors driving the North America Autoimmune Disease Diagnosis Market?

Key factors include the rising prevalence of autoimmune diseases, increased healthcare expenditure, and advancements in diagnostic technologies. For example, Thermo Fisher Scientific’s launch of novel autoantibody detection kits has accelerated early diagnosis, improving patient outcomes and boosting market growth across North America.

Which type accounted for the largest North America Autoimmune Disease Diagnosis Market share?

The consumables and assay kits segment captures the largest market share. Their essential role in high-frequency laboratory testing for autoimmune diseases, combined with the regular need for replenishment, ensures steady demand. Innovations in assay kit sensitivity and specificity further cement their leading position in the market.

Home Healthcare

North America Autoimmune Disease Diagnosis Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Name: North America Autoimmune Disease Diagnosis Market
Brand: Bussiness Insights

North America Autoimmune Disease Diagnosis Market: by Type (Systemic Autoimmune Disease, Localized Autoimmune Disease), Application (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Thyroiditis, Multiple Sclerosis, Type 1 Diabetes, Others), Distribution Channels (Hospital-based Laboratories, Independent Laboratories, Research Institutes, Others), Technology (ELISA, Immunoassays, Chemiluminescence Assay, Immunofluorescence Assay, Western Blotting, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20406 | Author: Manisha C

RD TOC Segmentation Research Methodology Request For Free Sample

North America Autoimmune Disease Diagnosis Market 2025-2035: Growth Trends, Segments & Leading Players Analysis

The North America Autoimmune Disease Diagnosis Market is witnessing significant growth, driven by advanced diagnostics adoption, rising prevalence of autoimmune disorders, and ongoing innovation by leading players. Increasing investment in R&D, along with strategic collaborations, are set to further expand market reach through 2035.

Latest Market Dynamics

Key Drivers

Rising Prevalence of Autoimmune Diseases: The growing incidence of conditions such as rheumatoid arthritis and type 1 diabetes is significantly increasing demand for advanced diagnostic solutions in North America. Major companies like Abbott Laboratories are expanding their diagnostic portfolios to address these conditions.

Technological Advancements in Diagnostics: Rapid innovation in diagnostic technologies, including the integration of ELISA, immunoassays, and next-generation sequencing, is enhancing the accuracy and reliability of autoimmune disease detection. Siemens Healthineers, for instance, has introduced high-sensitivity immunoassay platforms to meet evolving diagnostic needs.

Increasing Adoption of Automation: Automated testing solutions in laboratories are streamlining diagnostic workflows, reducing manual errors, and enhancing throughput. Thermo Fisher Scientific launched automated immunoassay analyzers in 2025, optimizing lab efficiency.
Strategic Collaborations & Mergers: Leading market players are increasingly engaging in partnerships to strengthen regional footprints and expand test menus. In June 2024, F. Hoffmann-La Roche Ltd announced a collaboration to co-develop autoimmune diagnostics with academic institutions.

Expansion into Emerging Segments: Companies are targeting emerging autoimmune disease segments, such as neurological and gastrointestinal disorders, leveraging research-driven product launches. Bio-Rad Laboratories expanded its range to include multiplex assays for multiple sclerosis in early 2025.
Personalized Diagnostic Solutions: The demand for tailored diagnostic tests is growing, driven by precision medicine trends. Quest Diagnostics has recently introduced patient-specific panels for autoimmune thyroiditis, enabling earlier and more precise interventions.

High Costs of Advanced Diagnostics: Premium pricing of new diagnostic technologies may limit accessibility for smaller labs and institutions. Smaller diagnostic centers face budgetary constraints in adopting cutting-edge platforms, as highlighted by ZEUS Scientific.
Complexity in Disease Differentiation: Differentiating between various autoimmune disorders remains a clinical challenge due to overlapping symptoms. Hologic, Inc. is working on advanced multiplex testing, but clinical implementation barriers persist.

Regulatory Hurdles: Stringent approval requirements for new diagnostic products delay time-to-market. Grifols, S.A. faces ongoing regulatory evaluations impacting rollout speeds for their latest autoimmune test kits.
Limited Reimbursement Policies: Inadequate reimbursement coverage for advanced autoimmune diagnostics restricts market growth, especially for innovative new entrants like SQI Diagnostics, who report slow reimbursement uptake in several North American regions.

Systemic Autoimmune Diseases account for the majority of diagnostic demand in North America, reflecting the high burden of conditions like rheumatoid arthritis and systemic lupus erythematosus. Localized autoimmune diseases and others, including auto-inflammatory and endocrine variants, continue to grow as awareness and diagnostic capabilities expand. The following chart illustrates the proportional market share by disease type for 2025.

Rheumatoid Arthritis leads the market share among autoimmune disease applications, driven by the high prevalence and demand for early detection. Type 1 Diabetes follows closely, supported by advances in diagnostic technology and screening programs. Other applications, including lupus, thyroiditis, and multiple sclerosis, make up the residual share as targeted diagnostic panels expand. The following chart visualizes the breakdown by application.

The North America Autoimmune Disease Diagnosis Market has demonstrated strong revenue growth from 2020, propelled by heightened disease awareness and ongoing technological innovation. The market is projected to reach 6,410 Million USD by 2025, rising consistently through 2035, reflecting investments in advanced diagnostics and expanded access across the region. The chart below highlights market revenue from 2020 to 2035.

The YOY growth rate for the North America Autoimmune Disease Diagnosis Market showcases healthy expansion, peaking during 2024-2027 as significant product launches and reimbursement expansions accelerate adoption. Growth moderates post-2030, indicating market maturity and increased competition. The following chart illustrates YOY growth trends from 2020 to 2035.

The United States dominates the North America Autoimmune Disease Diagnosis Market, capturing the largest share due to robust healthcare infrastructure, advanced laboratory technology, and strong R&D pipelines. Canada and Mexico collectively continue to grow, boosted by expanding healthcare access and government investments. This chart displays regional shares for 2025.

Abbott Laboratories, Siemens Healthineers, and F. Hoffmann-La Roche Ltd lead the competitive landscape, collectively securing a significant portion of the North America Autoimmune Disease Diagnosis Market by leveraging technological innovation, global distribution networks, and comprehensive diagnostic offerings. The chart below represents the market share of leading players in 2025.

Hospital-based laboratories are the primary buyers, reflecting their critical role in comprehensive autoimmune disease diagnosis infrastructure. Independent laboratories follow, supported by growing outsourcing trends and specialized test offerings. Research and academic institutions, along with other buyers, contribute to ongoing market expansion through investigative and clinical roles. The following chart highlights buyer market shares for 2025.

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	6410
Regions	North America (US, Canada, Mexico)
Segments	By Type: Systemic Autoimmune Disease, Localized Autoimmune Disease, Auto-inflammatory Diseases, Endocrine Autoimmune Disease, Gastrointestinal Autoimmune Disease, Other Types; By Application: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Thyroiditis, Multiple Sclerosis, Type 1 Diabetes, Other Applications
Players	Abbott Laboratories, Siemens Healthineers, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Werfen, Quest Diagnostics, bioMérieux SA, Trinity Biotech plc, EUROIMMUN (PerkinElmer), Grifols, S.A., Hologic, Inc., ZEUS Scientific, Inc., SQI Diagnostics

In June 2024, Siemens Healthineers launched its Atellica Solution immunoassay analyzer, enhancing throughput for autoimmune diagnostic labs.
In July 2024, F. Hoffmann-La Roche Ltd entered a strategic partnership with leading North American academic medical centers to co-develop new autoimmune markers.
In August 2024, Abbott Laboratories rolled out next-generation multiplex diagnostic panels for integrated autoimmune disease detection.
In September 2024, Quest Diagnostics announced direct-to-consumer autoimmune disease testing solutions in major North American cities.
In October 2024, Thermo Fisher Scientific introduced an expanded suite of ELISA-based autoimmune diagnostic kits across the US and Canada.

About the Author

Manisha C

Lead Industry Analyst

Manisha C is a Lead Industry Analyst specializing in market research, industry analysis, and business consulting across Healthcare. Manisha C brings a commercially grounded perspective to sectors shaped by changing demand, innovation, and competitive dynamics, helping turn complex market trends into clear strategic insights for business decision-makers. With 10+ years of experience across research, analytics, and strategic advisory roles, Manisha C has helped organizations translate data into actionable growth strategies.

HealthcareMarket ResearchIndustry AnalysisStrategic Consulting

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Download Sample

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

Speak to Analyst

North America Autoimmune Disease Diagnosis Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

North America Autoimmune Disease Diagnosis Market 2025-2035: Growth Trends, Segments & Leading Players Analysis

Latest Market Dynamics

Key Drivers

Key Trends

Key Opportunities

Key Challenges

Key Restraints

Market Share by Disease Type, 2025

Market Share by Application, 2025

Market Revenue (USD Million), 2020-2035

Year-on-Year (YOY) Growth (%), 2020-2035

Regional Market Share, 2025

Top Market Players Share, 2025

Market Share by Buyer Type, 2025

Study Coverage

Key Recent Developments

Frequently Asked Questions

About the Author

Related Reports